Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by wagyusteakon Nov 13, 2020 1:06pm
118 Views
Post# 31895915

RE:RE:RE:RE:RE:Does anyone sell today?? Let me buy your shares @ $1-$3

RE:RE:RE:RE:RE:Does anyone sell today?? Let me buy your shares @ $1-$3
porksniffer wrote:
wagyusteak wrote:
Snowballgrowth wrote:
Benedict16th wrote: The market is so inpressed of this MNGT team Q3 report. The share price shot up by hge 5 cents.  OMG ...The exit door is getting closer and closer for mngt. Ne new deal, not guidence and 400 millions idle. If  six years ago you blind folded  a monkey with darts shooting on a board to selcts investments to buy for a billion dollars worth the monkey would have done a hell of a lot better with a 10% yearly return 


The reps can't go to see the doctors


he doesn't read the reports or listen to the earnings call. All he cares is the stock price. If it goes up, it means good. If it goes down, it means bad. The stock price tells him everything he needs to know.



You must be pretty thick.

That is exactly how it is. Mangagement is judged by investment returns. Nothing else. Institutions play this game to PROFIT not lose. If there is no marked improvment in stock price now that this debacle of an acquistion is complete, CEO will be gone in 12-15 months. Mark this post. And Mugnuts can come here and spew his '270 shareholders have voted' rubbish lol....

No real net income other than accounting shenanhigans now that the only good investment (Medison) is gone.loolol ok. 

Everything that Meir said would happen has happened. Everything. He warned of this exact performace and outcome, a confusing company littered with small investments in small 3rd world companies would result in trading at a discount to NAV

[/quote]

then why the f are you still here?? Get out babyyy.

Bullboard Posts